Microdosing

What is Microdosing?

Off-label use of doses below the approved range, to soften side effects or stretch a vial.

Evidence is thin: the published randomized data were all run at approved doses. It is now sold as its own product tier, and whether it is cheaper than a standard dose depends far more on the commitment term than on the dose.

Semaglutide microdosing evidence →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where Microdosing comes up on this site

On GLP Watchdog, Microdosing comes up in 2 research articles and 22 seller reviews.

Other terms under Patient experience

• Plateau
• Switching GLP-1s
• Rebound weight gain
• GLP-1 + anesthesia (preoperative)
• Subcutaneous (subq) injection
• GLP-1 in pregnancy
• Intensive Behavioral Therapy (IBT)

Where the evidence lives

• Semaglutide microdosing evidence
• The full GLP-1 glossary (149 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers